Novel substituted naphthalen-1-yl-methanone derivatives as anti-hyperglycemic agents

Bioorg Med Chem Lett. 2006 May 15;16(10):2719-23. doi: 10.1016/j.bmcl.2006.02.013. Epub 2006 Feb 24.

Abstract

A series of aminoalkoxy phenyl-substituted naphthalene-1-yl-methanone was synthesized and tested for its anti-hyperglycemic activity in SLM and STZ-S rat models. Some compounds (3b, 4c and 4h) of the series were showing significant anti-hyperglycemic activity in male Sprague-Dawley rats in sucrose-loaded model (SLM) as well as in streptozotocin-induced model (STZ-S). Active compounds were also evaluated for relative binding affinity against glucagon receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / analysis
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / drug therapy
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology*
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Naphthalenes / chemistry
  • Naphthalenes / pharmacology*
  • Naphthalenes / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Streptozocin

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Naphthalenes
  • naphthalene
  • Streptozocin